Agritech Innovation

As an ethical company we traditionally defined our social and economic impact in the following of ways.

Cardiovascular and Cognitive health

Economic impact through our supply chain

Empowerment of women as a distinct output of our intervention.

We have now abandoned this outdated paradigm and have moved to a more valuable construct.

Two-thirds of the global extreme poor earn their livelihood in farming and productivity growth in agriculture. This has the largest impact of any sector on poverty reduction. Rising agricultural productivity in China and other countries of East Asia has contributed to impressive reductions in poverty, but has been too low to have similar impacts in Africa, Latin America and in South Asia, precisely where the largest remaining pockets of extreme poverty are to be found. The modest expansion of urban manufacturing and service sectors is unlikely to provide alternative income sources over the medium term.

[The World bank Harvesting Prosperity Technology and Productivity Growth in Agriculture Keith Fuglie, Madhur Gautam, Aparajita Goyal, and William F. Maloney

We are now aspire to work in San Salvador and Guatemala above and beyond a supply chain presence. If the company is to benefit through the manufacture of better and more powerful therapeutic products it will not only have to purchase cacao but work with a number of institutions that support cacao farmers, carry out research on cacao [See Cacao Science.] We recognise that we will have to work closely with the governments of both countries to establish a long term partnership to develop an Innovative Agritech model based on a cacao flavanol technology developed and patented in the UK. The company’s’ Intellectual Property [IP] supported with the relevant Knowledge Transfer [KT] of pure cacao will be utilised to make products for nutritional, cosmeceutical, nutraceutical medical uses.

The realisable objectives will be to;-

Impact the agricultural and food processing sector in the economy creating jobs and in increasing employability and reducing poverty in rural areas.

The medium term impact will be to develop a bio-engineering capability to support nutraceutical manufacturing of nutritional food products. This has ae preventive effects on hypertension, diabetes and inflammatory processes. These are both global and national killers as they are the causes of the highest morbidity and mortality in El Salvador. Additionally they place a high burden on health systems.

The final objective will be to manufacture high value cardiovascular and neuroprotective therapeutics for export into the USA. Latin America and Canada